Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis

被引:2
|
作者
Shingala, Kishan [1 ]
Stavros, Sarah [2 ]
Parag, Sonam [1 ]
Tercek, Abigail [2 ]
Makhani, Sarah S. [2 ]
Bouz, Antoun [2 ]
Galbo, Alexandra [2 ]
Chung-Bridges, Katherine [3 ]
机构
[1] Nova Southeastern Univ, Coll Med, Dr Kiran C Patel Coll Allopath Med, Davie, FL USA
[2] Florida Int Univ FIU, Med & Populat Hlth Sci Res, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[3] Hlth Choice Network, Res, Miami, FL USA
关键词
serous ovarian carcinoma; overall survival (os); survival analyses; racial inequalities; high-grade serous ovarian carcinoma; WOMEN; HEALTH; RACE;
D O I
10.7759/cureus.34389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify racial disparities in five-year survival rates in women affected by serous epithelial ovarian carcinoma in the United States (US).Methods: This retrospective cohort study analyzed data from the 2010 to 2016 Surveillance, Epidemiology, and End Results (SEER) program database. Women with a primary malignancy of serous epithelial ovarian carcinoma, using International Classification of Diseases for Oncology (ICD-O) Topography Coding and ICD-O-3 Histology Coding, were included in this study. Race and ethnicity were combined into the following groups: Non-Hispanic White (NHW), Non-Hispanic Black (NHB), Non-Hispanic Asian/Pacific Islander (NHAPI), Non-Hispanic Other (NHO), and Hispanics. Cancer-specific survival was measured at five years post-diagnosis. A comparison of baseline characteristics was assessed using Chi-squared tests. Unadjusted and adjusted Cox regression models were used to calculate hazard ratios (HR) and corresponding 95% confidence intervals (CI).Results: From 2010 to 2016, there were 9,630 women with a primary diagnosis of serous ovarian carcinoma identified in the SEER database. A higher proportion of Asian/PI women (90.7%) were diagnosed with high-grade malignancy (poorly differentiated/undifferentiated) compared to NHW women (85.4%). NHB women (9.7%) were less likely to undergo surgery when compared to NHW women (6.7%). Hispanic women had the highest proportion of uninsured women (5.9%), while NHW and NHAPI had the lowest (2.2% each). A higher proportion of NHB (74.2%) and Asian/PI (71.3%) women presented with the distant disease compared to NHW women (70.2%). After adjustment for age, insurance, marital status, stage, metastases, and surgical resection, NHB women had the highest hazard of death within five years compared to NHW women (adjusted (adj) HR 1.22, 95% CI 1.09-1.36, p<0.001). Hispanic women also had lower five-year survival probabilities compared to NHW women (adj HR 1.21, 95% CI 1.12-1.30, p<0.001). Patients undergoing surgery had significantly increased survival probability compared to those who did not (p<0.001). As expected, women with Grade III and Grade IV disease both had significantly lower five-year survival probabilities compared to Grade I (p<0.001).Conclusion: This study reveals that there is an association between race and overall survival in patients with serous ovarian carcinoma, with NHB and Hispanic women having the highest hazards of death compared to NHW women. This adds to the existing body of literature as survival outcomes in Hispanic patients relative to NHW patients are not well documented. Because of the potential interplay between overall survival and several factors including race, future studies should aim to investigate other socioeconomic factors that may be impacting survival.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Racial disparities in women with serous epithelial ovarian cancer: a Surveillance, Epidemiology, and End Results (SEER) survival analysis
    Tercek, Abigail
    Galbo, Alexandra
    Makhani, Sarah
    Bouz, Antoun
    Chung-Bridges, Katherine
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S251 - S252
  • [2] Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis
    Habis, Mohammed
    Wroblewski, Kristen
    Bradaric, Michael
    Ismail, Nadia
    Yamada, S. Diane
    Litchfield, Lacey
    Lengyel, Ernst
    Romero, Iris L.
    PLOS ONE, 2014, 9 (08):
  • [3] Factors leading to racial disparities in treatment and outcomes of epithelial ovarian cancer
    Erickson, B.
    Martin, J.
    Shah, M.
    Fauci, J.
    Daily, L.
    Pasko, D.
    Walters, C.
    Leath, C.
    Straughn, J.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 280 - 281
  • [4] Impact of Histology on Racial Disparities in Epithelial Ovarian Cancer Patients
    Craig, Eric R.
    Tarney, Christopher
    Tian, Chunqiao
    Casablanca, Yovanni
    Darcy, Kathleen
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 201S - 202S
  • [5] Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States
    Chan, John K.
    Zhang, Mallory
    Hu, Jessica M.
    Shin, Jacob Y.
    Osann, Kathryn
    Kapp, Daniel S.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (02) : 103 - 107
  • [6] Racial/ethnic disparities in ovarian cancer survival
    Khanna, N.
    Hu, J.
    Allen, G.
    Clarke, J.
    Lucci, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S114 - S114
  • [7] Racial Disparities in the Treatment of Advanced Epithelial Ovarian Cancer
    Howell, Elizabeth A.
    Egorova, Natalia
    Hayes, Monica P.
    Wisnivesky, Juan
    Franco, Rebeca
    Bickell, Nina
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (05): : 1025 - 1032
  • [8] Maximal Effort Cytoreduction in Epithelial Ovarian Cancer: Perioperative Complications and Survival Outcomes from a Retrospective Cohort
    Haidopoulos, Dimitrios
    Pergialiotis, Vasilios
    Zachariou, Eleftherios
    Sapantzoglou, Ioakim
    Thomakos, Nikolaos
    Stamatakis, Emmanouil
    Alexakis, Nikolaos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [9] Racial Disparities and Survival Outcomes in Breast Cancer
    Shigeta, Haruki
    Ozaki, Akihiko
    Tanimoto, Tetsuya
    JAMA ONCOLOGY, 2024, 10 (01) : 140 - 141
  • [10] Racial disparities in treatment and survival from ovarian cancer
    Hildebrand, Janet S.
    Wallace, Kristin
    Graybill, Whitney S.
    Kelemen, Linda E.
    CANCER EPIDEMIOLOGY, 2019, 58 : 77 - 82